Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Arcadia Biosciences (RKDA) is now available.
Arcadia Biosciences, Inc. has elevated Thomas J. Schaefer to a Class I director position following Stanley Jacot’s resignation. Schaefer, who has been with Arcadia since 2020 and its president and CEO since 2022, brings a robust financial background to the role, including a past as a finance director in the food industry and an equity research analyst. His academic credentials include a BBA and an MBA from prestigious institutions, underscoring his expertise in economics and finance.
See more data about RKDA stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue